Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023-04 · 21 (4) · 393-422
DOI: 10.6004/jnccn.2023.0019 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2023-04. Verfasst von Jaffer A Ajani und 41 weiteren Autor:innen. Beteiligte Einrichtung: The University of Texas MD Anderson Cancer Center. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms, Second Primary. Die Arbeit wurde bisher 558-mal zitiert (Crossref) und nennt 191 Literaturangaben.
Abstract (Originalsprache)
Cancers originating in the esophagus or esophagogastric junction constitute a major global health problem. Esophageal cancers are histologically classified as squamous cell carcinoma (SCC) or adenocarcinoma, which differ in their etiology, pathology, tumor location, therapeutics, and prognosis. In contrast to esophageal adenocarcinoma, which usually affects the lower esophagus, esophageal SCC is more likely to localize at or higher than the tracheal bifurcation. Systemic therapy can provide palliation, improved survival, and enhanced quality of life in patients with locally advanced or metastatic disease. The implementation of biomarker testing, especially analysis of HER2 status, microsatellite instability status, and the expression of programmed death-ligand 1, has had a significant impact on clinical practice and patient care. Targeted therapies including trastuzumab, nivolumab, ipilimumab, and pembrolizumab have produced encouraging results in clinical trials for the treatment of patients with locally advanced or metastatic disease. Palliative management, which may include systemic therapy, chemoradiation, and/or best supportive care, is recommended for all patients with unresectable or metastatic cancer. Multidisciplinary team management is essential for all patients with locally advanced esophageal or esophagogastric junction cancers. This selection from the NCCN Guidelines for Esophageal and Esophagogastric Junction Cancers focuses on the management of recurrent or metastatic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The University of Texas MD Anderson Cancer Center.
- Duke Cancer Institute.
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
- UC Davis Comprehensive Cancer Center.
- UCSF Helen Diller Family Comprehensive Cancer Center.
- Dana-Farber/Brigham and Women's Cancer Center.
Zitieren
APA
Ajani, J. A., D'Amico, T. A., Bentrem, D. J., Cooke, D., Corvera, C., Das, P., Enzinger, P. C., Enzler, T., Farjah, F., Gerdes, H., Gibson, M., Grierson, P., Hofstetter, W. L., Ilson, D. H., Jalal, S., Keswani, R. N., Kim, S., Kleinberg, L. R., Klempner, S., …, & Pluchino, L. A. (2023). Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 21(4), 393-422. https://doi.org/10.6004/jnccn.2023.0019
Vancouver
Ajani JA, D'Amico TA, Bentrem DJ, Cooke D, Corvera C, Das P, et al. Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2023;21(4):393-422. doi:10.6004/jnccn.2023.0019
BibTeX
@article{Ajani2023,
author = {Ajani, Jaffer A and D'Amico, Thomas A and Bentrem, David J and Cooke, David and Corvera, Carlos and Das, Prajnan and Enzinger, Peter C and Enzler, Thomas and Farjah, Farhood and Gerdes, Hans and Gibson, Michael and Grierson, Patrick and Hofstetter, Wayne L and Ilson, David H and Jalal, Shadia and Keswani, Rajesh N and Kim, Sunnie and Kleinberg, Lawrence R and Klempner, Samuel and Lacy, Jill and Licciardi, Frank and Ly, Quan P and Matkowskyj, Kristina A and McNamara, Michael and Miller, Aaron and Mukherjee, Sarbajit and Mulcahy, Mary F and Outlaw, Darryl and Perry, Kyle A and Pimiento, Jose and Poultsides, George A and Reznik, Scott and Roses, Robert E and Strong, Vivian E and Su, Stacey and Wang, Hanlin L and Wiesner, Georgia and Willett, Christopher G and Yakoub, Danny and Yoon, Harry and McMillian, Nicole R and Pluchino, Lenora A},
title = {Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2023},
volume = {21},
number = {4},
pages = {393--422},
doi = {10.6004/jnccn.2023.0019}
}
EUVIMED